Real-time enrollment status for this pancreatic ductal adenocarcinoma (pdac) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:03 AM UTC
| NCT Number | NCT03977233 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma (PDAC) |
| Phase | PHASE2 |
| Target Enrollment | 45 participants |
| Active Locations | 1 sites in the US |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Last Updated on CT.gov | January 13, 2026 (Jan 13, 2026) |
As of July 18, 2026: Clinical trial NCT03977233 is currently recruiting participants. This phase2 study for pancreatic ductal adenocarcinoma (pdac) is actively seeking new participants at 1 location across the United States. The study is sponsored by UNC Lineberger Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03977233 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03977233 was last updated Jan 13, 2026 (January 13, 2026). HelloStudys verifies this status automatically.